{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:27:40Z","timestamp":1787041660599,"version":"build-2736575974"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Commission of Health and Family Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ejmech.2026.119093","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:15:05Z","timestamp":1782400505000},"page":"119093","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of potent BChE\/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosis"],"prefix":"10.1016","volume":"317","author":[{"given":"Yuanyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangdi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baichen","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5109-0304","authenticated-orcid":false,"given":"Haopeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119093_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3390\/neurolint17060092","article-title":"Global diseases deserve global solutions: alzheimer's disease","volume":"17","author":"Twiss","year":"2025","journal-title":"Neurol. Int."},{"key":"10.1016\/j.ejmech.2026.119093_bib2","first-page":"273","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism","volume":"171","author":"Stockwell","year":"2017","journal-title":"Redox Biol. Dis. Cell"},{"key":"10.1016\/j.ejmech.2026.119093_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bj.2018.01.003","article-title":"Tau and neuroinflammation: what impact for alzheimer's disease and tauopathies?","volume":"41","author":"Laurent","year":"2018","journal-title":"Biomed. J."},{"key":"10.1016\/j.ejmech.2026.119093_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11033-023-09021-z","article-title":"Oxidative stress in Alzheimer's disease: current knowledge of signaling pathways and therapeutics","volume":"51","author":"Dhapola","year":"2024","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejmech.2026.119093_bib5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119093_bib6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer's disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2026.119093_bib7","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3390\/biomedicines9111689","article-title":"Efficacy of acetylcholinesterase inhibitors on cognitive function in Alzheimer's disease. Review of reviews","volume":"9","author":"Perez-Gomez Moreta","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2026.119093_bib8","volume":"vol 104","author":"Singh","year":"2024"},{"key":"10.1016\/j.ejmech.2026.119093_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamaneurol.2021.5205","article-title":"Amyloid-related imaging abnormalities and \u03b2-Amyloid-Targeting antibodies A systematic review","volume":"79","author":"Filippi","year":"2022","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2026.119093_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101206","article-title":"Nrf2: a dark horse in Alzheimer's disease treatment","volume":"64","author":"Osama","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119093_bib11","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1039\/D4SC06762B","article-title":"Multi-target-directed therapeutic strategies for Alzheimer's disease: controlling amyloid-\u03b2 aggregation, metal ion homeostasis, and enzyme inhibition","volume":"16","author":"Yoo","year":"2025","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2026.119093_bib12","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/med.21745","article-title":"Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer's disease, and fat metabolism","volume":"41","author":"Xing","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119093_bib13","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/(SICI)1096-9861(19980413)393:3<374::AID-CNE8>3.0.CO;2-Z","article-title":"Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation","volume":"393","author":"Darvesh","year":"1998","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejmech.2026.119093_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00002093-199501002-00005","article-title":"Cholinesterases and the pathology of alzheimer-disease","volume":"9","author":"Geula","year":"1995","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.ejmech.2026.119093_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1023\/A:1022869222652","article-title":"Cholinesterases: new roles in brain function and in Alzheimer's disease","volume":"28","author":"Giacobini","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2026.119093_bib16","article-title":"Genetic and functional dynamics of butyrylcholinesterase in Alzheimer's disease: from mechanisms to clinical relevance","volume":"423","author":"Presern","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2026.119093_bib17","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer \u03b2-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119093_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129436","article-title":"The structural modification and biological evaluation of tetrahydrothienopyridine derivatives as selective BChE inhibitors","volume":"93","author":"Chen","year":"2023","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119093_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116463","article-title":"Discovery of 4-benzylpiperazinequinoline BChE inhibitor that suppresses neuroinflammation for the treatment of Alzheimer's disease","volume":"272","author":"Chen","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib20","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1021\/acs.jmedchem.2c00944","article-title":"N-Benzyl benzamide derivatives as selective sub-nanomolar butyrylcholinesterase inhibitors for possible treatment in advanced Alzheimer's disease","volume":"65","author":"Du","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib21","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1021\/acs.jmedchem.1c00167","article-title":"Highly potent and selective butyrylcholinesterase inhibitors for cognitive improvement and neuroprotection","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114510","article-title":"A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement","volume":"239","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bioorg.2018.12.023","article-title":"Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation","volume":"85","author":"Lu","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103310","article-title":"Design, synthesis, biological evaluation, and molecular modeling studies of quinoline-ferulic acid hybrids as cholinesterase inhibitors","volume":"93","author":"Mo","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib25","doi-asserted-by":"crossref","DOI":"10.1177\/1559325820938526","article-title":"Discovery of a selective 6-Hydroxy-1, 4-Diazepan-2-one containing butyrylcholinesterase inhibitor by virtual screening and MM-GBSA rescoring","volume":"18","author":"Zhou","year":"2020","journal-title":"Dose Response"},{"key":"10.1016\/j.ejmech.2026.119093_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114729","article-title":"Design, synthesis, and biological evaluation of aromatic tertiary amine derivatives as selective butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease","volume":"243","author":"Lu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101503","article-title":"Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies","volume":"72","author":"Song","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2026.119093_bib28","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000283480","article-title":"Neuroinflammation - an early event in both the history and pathogenesis of Alzheimer's disease","volume":"7","author":"Eikelenboom","year":"2010","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.ejmech.2026.119093_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12017-018-08523-5","article-title":"Therapeutic approaches to Alzheimer's disease through modulation of NRF2","volume":"21","author":"Bahn","year":"2019","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.ejmech.2026.119093_bib30","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.ejmech.2018.08.071","article-title":"Structure-activity and structure-property relationships of novel Nrf2 activators with a 1,2,4-oxadiazole core and their therapeutic effects on acetaminophen (APAP)-induced acute liver injury","volume":"157","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib31","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/jm5000529","article-title":"Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis","volume":"57","author":"Jiang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib32","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1021\/jm2002348","article-title":"Novel Chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells","volume":"54","author":"Kumar","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib33","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.1021\/acs.jmedchem.5b00602","article-title":"Design, synthesis, and evaluation of triazole derivatives that induce Nrf2 dependent gene products and inhibit the Keap1-Nrf2 protein-protein interaction","volume":"58","author":"Bertrand","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib34","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1021\/acs.jmedchem.3c02171","article-title":"Optimization efforts for identification of novel highly potent Keap1-Nrf2 protein-protein interaction inhibitors","volume":"67","author":"Otake","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1021\/acs.jmedchem.8b01527","article-title":"Optimization of vinyl sulfone derivatives as potent nuclear factor erythroid 2-Related factor 2 (Nrf2) activators for Parkinson's disease therapy","volume":"62","author":"Choi","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib36","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119093_bib37","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","article-title":"The cell biology of ferroptosis","volume":"25","author":"Dixon","year":"2024","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119093_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/jnc.15833","article-title":"Butyrylcholinesterase in lipid metabolism: a new outlook","volume":"168","author":"Gok","year":"2024","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2026.119093_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/NEN.0b013e31823cc7a6","article-title":"Butyrylcholinesterase is associated with \u03b2-Amyloid plaques in the transgenic APPSWE\/PSEN1dE9 mouse model of alzheimer disease","volume":"71","author":"Darvesh","year":"2012","journal-title":"JNEN (J. Neuropathol. Exp. Neurol.)"},{"key":"10.1016\/j.ejmech.2026.119093_bib40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/ana.410420613","article-title":"Butyrylcholinesterase in the life cycle of amyloid plaques","volume":"42","author":"Guillozet","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmech.2026.119093_bib41","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1073\/pnas.0602922103","article-title":"Butyrylcholinesterase attenuates amyloid fibril formation in vitro","volume":"103","author":"Diamant","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119093_bib42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer's disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2026.119093_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117146","article-title":"Dual functional antioxidant and butyrylcholinesterase inhibitors for the treatment of Alzheimer's disease: design, synthesis and evaluation of novel melatonin-alkylbenzylamine hybrids","volume":"78","author":"Liu","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib44","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1021\/acs.jmedchem.6b01178","article-title":"The antioxidant additive approach for Alzheimer's disease therapy: new ferulic (lipoic) acid plus melatonin modified tacrines as cholinesterases inhibitors, direct antioxidants, and nuclear factor (Erythroid-Derived 2)-Like 2 activators","volume":"59","author":"Benchekroun","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib45","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1016\/j.bmc.2015.06.010","article-title":"Structure-based development of nitroxoline derivatives as potential multifunctional anti-alzheimer agents","volume":"23","author":"Knez","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib46","doi-asserted-by":"crossref","first-page":"10030","DOI":"10.1021\/acs.jmedchem.0c01129","article-title":"Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112874","article-title":"Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3\u03b2 inhibitors and evaluation of their potential as multifunctional anti-alzheimer agents","volume":"209","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib48","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1016\/j.bmcl.2013.06.042","article-title":"Novel pyrazoline amidoxime and their 1,2,4-oxadiazole analogues: synthesis and pharmacological screening","volume":"23","author":"Ningaiah","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119093_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200045","article-title":"A comprehensive review of recent advances in the biological activities of 1,2,4-oxadiazoles","volume":"355","author":"Hendawy","year":"2022","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2026.119093_bib50","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1016\/j.bmc.2016.05.056","article-title":"Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core","volume":"24","author":"Xu","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib51","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/10286020.2018.1492566","article-title":"Synthesis and evaluation of coumarin\/1,2,4-oxadiazole hybrids as selective BChE inhibitors with neuroprotective activity","volume":"21","author":"Zhang","year":"2019","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.ejmech.2026.119093_bib52","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1021\/acs.jmedchem.5b00170","article-title":"Discovery and modification of in vivo active Nrf2 activators with 1,2,4-Oxadiazole core: hits identification and structure-activity relationship study","volume":"58","author":"Xu","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib53","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib54","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","article-title":"Monoacidic inhibitors of the kelch-like ECH-associated protein 1: nuclear factor erythroid 2-Related factor 2 (KEAP1:NRF2) protein protein interaction with high cell potency identified by fragment-based discovery","volume":"59","author":"Davies","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2019.126852","article-title":"Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators","volume":"30","author":"Ma","year":"2020","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2026.119093_bib56","doi-asserted-by":"crossref","first-page":"8289","DOI":"10.1021\/acs.jmedchem.2c00170","article-title":"Crystallography-guided optimizations of the Keap1-Nrf2 inhibitors on the solvent exposed region: from symmetric to asymmetric naphthalenesulfonamides","volume":"65","author":"Liu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib57","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1128\/MCB.01191-13","article-title":"Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1","volume":"34","author":"Fukutomi","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119093_bib58","doi-asserted-by":"crossref","first-page":"11430","DOI":"10.1021\/acs.jmedchem.9b01446","article-title":"Ligand-based design of Nondimethylphenyl-Diarylpyrimidines with improved metabolic stability, safety, and oral pharmacokinetic profiles","volume":"62","author":"Sang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib59","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1016\/j.apsb.2025.06.016","article-title":"Bioisosterism-driven design of orally active, safe, and broad-spectrum biphenyl-DAPY derivatives as highly potent HIV-1 non-nucleoside reverse transcriptase inhibitors","volume":"15","author":"Chen","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119093_bib60","doi-asserted-by":"crossref","first-page":"15259","DOI":"10.1073\/pnas.1305687110","article-title":"Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex","volume":"110","author":"Baird","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2026.119093_bib61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1039\/C6MD00500D","article-title":"Small molecules inhibiting Keap1-Nrf2 protein-protein interactions: a novel approach to activate Nrf2 function","volume":"8","author":"Zhuang","year":"2017","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2026.119093_bib62","doi-asserted-by":"crossref","first-page":"8088","DOI":"10.1021\/acs.jmedchem.8b00358","article-title":"Non-covalent small-molecule kelch-like ECH-associated protein 1-Nuclear factor erythroid 2-Related factor 2 (Keap1-Nrf2) inhibitors and their potential for targeting central nervous system diseases","volume":"61","author":"Pallesen","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib63","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP 1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119093_bib64","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119093_bib65","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/ars.2016.6925","article-title":"Redox signaling mediated by thioredoxin and glutathione systems in the central nervous system","volume":"27","author":"Ren","year":"2017","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.ejmech.2026.119093_bib66","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1089\/ars.2018.7509","article-title":"Redox biology in neurological function, dysfunction, and aging","volume":"28","author":"Franco","year":"2018","journal-title":"Antioxid. Redox Signaling"},{"key":"10.1016\/j.ejmech.2026.119093_bib67","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.1021\/jm500258v","article-title":"Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents","volume":"57","author":"Ning","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib68","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1021\/acs.jmedchem.5b00410","article-title":"Synthesis of piperlongumine analogues and discovery of nuclear factor erythroid 2-related factor 2 (Nrf2) activators as potential neuroprotective agents","volume":"58","author":"Peng","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib69","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.freeradbiomed.2019.01.003","volume":"134","author":"Xu","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2026.119093_bib70","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","article-title":"Anti-amyloid immunotherapies for Alzheimer\u2019s disease: a 2023 clinical update","volume":"20","author":"Yadollahikhales","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmech.2026.119093_bib71","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijbiomac.2018.10.021","article-title":"Fucosterol exerts protection against amyloid beta-induced neurotoxicity, reduces intracellular levels of amyloid beta and enhances the mRNA expression of neuroglobin in amyloid beta-induced SH-SY5Y cells","volume":"121","author":"Gan","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119093_bib72","first-page":"1857","article-title":"Morphological observation of cellular uptake of beta amyloid protein in cultured human neuroblastoma cells","volume":"29","author":"Qian","year":"2009","journal-title":"J. South. Med. Univ."},{"key":"10.1016\/j.ejmech.2026.119093_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.11.017","article-title":"NRF2 and NF-kappa B interplay in cerebrovascular and neurodegenerative disorders: molecular mechanisms and possible therapeutic approaches","volume":"21","author":"Sivandzade","year":"2019","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejmech.2026.119093_bib74","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3390\/antiox10020218","article-title":"Implication of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and its inhibitors in Alzheimer's disease murine models","volume":"10","author":"Fragoso-Morales","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.ejmech.2026.119093_bib75","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2026.119093_bib76","first-page":"136","article-title":"Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease","volume":"3","author":"Wang","year":"2015","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.119093_bib77","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1038\/s41418-020-00685-9","article-title":"Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease","volume":"28","author":"Bao","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.119093_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2026.119093_bib79","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119093_bib80","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","article-title":"The blood-brain barrier (BBB) score","volume":"62","author":"Gupta","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib81","doi-asserted-by":"crossref","first-page":"9116","DOI":"10.1021\/acs.jmedchem.9b01012","article-title":"Highly selective butyrylcholinesterase inhibitors with tunable duration of action by chemical modification of transferable carbamate units exhibit pronounced neuroprotective effect in an Alzheimer's disease mouse model","volume":"62","author":"Hoffmann","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119093_bib82","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1016\/j.apsb.2025.07.005","article-title":"Pleiotropic prodrugs for both symptomatic and disease-modifying treatment of Alzheimer's disease","volume":"15","author":"Meden","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119093_bib83","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1021\/acs.jmedchem.5c00577","article-title":"Lead optimization of a butyrylcholinesterase inhibitor for the treatment of Alzheimer's disease","volume":"68","author":"Kosak","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426005386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:03:05Z","timestamp":1787040185000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426005386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":83,"alternative-id":["S0223523426005386"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119093","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of potent BChE\/Nrf2 modulators for Alzheimer's disease treatment via dual suppression of ferroptosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119093","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119093"}}